Literature DB >> 6301008

Serum ferritin as a predictor of host response to hepatitis B virus infection.

E D Lustbader, H W Hann, B S Blumberg.   

Abstract

With hemodialysis patients, a high serum ferritin before there was serological evidence of hepatitis B virus infection increased the likelihood that the infection would be persistent. This finding suggested that hepatitis B virus is likely to infect and actively replicate in liver cells with the propensity for increased ferritin synthesis. The virus itself could stimulate the synthesis of ferritin in a cyclic positive feedback mechanism that increases intracellular ferritin concentration and, eventually, intracellular iron. Transformed liver cells have low iron content, do not replicate hepatitis B virus, and require iron for growth. Infected, nonmalignant liver cells could supply iron to the transformed cells and nourish their expansion.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6301008     DOI: 10.1126/science.6301008

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  17 in total

1.  Iron and hepatitis C.

Authors:  B R Bacon
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

2.  Iron, HCV and the liver.

Authors:  K P Maier
Journal:  World J Gastroenterol       Date:  1997-06-15       Impact factor: 5.742

3.  Hepatic iron deprivation prevents spontaneous development of fulminant hepatitis and liver cancer in Long-Evans Cinnamon rats.

Authors:  J Kato; M Kobune; Y Kohgo; N Sugawara; H Hisai; T Nakamura; S Sakamaki; N Sawada; Y Niitsu
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

Review 4.  Plasma ferritin determination as a diagnostic tool.

Authors:  C A Finch; V Bellotti; S Stray; D A Lipschitz; J D Cook; M J Pippard; H A Huebers
Journal:  West J Med       Date:  1986-11

5.  Iron increases HMOX1 and decreases hepatitis C viral expression in HCV-expressing cells.

Authors:  Wei-Hong Hou; Lisa Rossi; Ying Shan; Jian-Yu Zheng; Richard-W Lambrecht; Herbert-L Bonkovsky
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

6.  Successful treatment with lamivudine may correlate with reduction of serum ferritin levels in the patients with chronic hepatitis and liver cirrhosis type B.

Authors:  Shogo Ohkoshi; Akira Yoshimura; Satoshi Yamamoto; Masahiko Yano; So Kurita; Kazuhide Yamazaki; Yo-Hei Aoki; Satoshi Yamagiwa; Hiroto Wakabayashi; Motoya Sugiyama; Tohru Takahashi; Tohru Ishikawa; Yasunobu Matsuda; Takafumi Ichida; Tomoteru Kamimura; Yutaka Aoyagi
Journal:  Hepatol Int       Date:  2008-07-25       Impact factor: 6.047

Review 7.  Iron withholding: a defense against viral infections.

Authors:  E D Weinberg
Journal:  Biometals       Date:  1996-10       Impact factor: 2.949

8.  Sequential changes of serum ferritin levels and their clinical significance in lamivudine-treated patients with chronic viral hepatitis B.

Authors:  Zheng-Wen Liu; Qun-Ying Han; Ni Zhang; Wen Kang
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

Review 9.  HFE gene in primary and secondary hepatic iron overload.

Authors:  Giada Sebastiani; Ann-P Walker
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

10.  Serum ferritin is a clinical biomarker in Japanese patients with nonalcoholic steatohepatitis (NASH) independent of HFE gene mutation.

Authors:  Masato Yoneda; Yuichi Nozaki; Hiroki Endo; Hironori Mawatari; Hiroshi Iida; Koji Fujita; Kyoko Yoneda; Hirokazu Takahashi; Hiroyuki Kirikoshi; Masahiko Inamori; Noritoshi Kobayashi; Kensuke Kubota; Satoru Saito; Shiro Maeyama; Kikuko Hotta; Atsushi Nakajima
Journal:  Dig Dis Sci       Date:  2009-03-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.